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Background: The prevalence of equine herpesvirus types-1 and -4 (EHV-1 and -4) in South African Thoroughbreds
at auction sales is currently undefined. Commingling of young Thoroughbreds from various populations together
with physiological stress related to their transport and confinement at a sales complex, may be associated with
shedding and transmission of EHV-1 and -4. This prospective cohort study sampled 90 young Thoroughbreds
consigned from eight farms, originating from three provinces representative of the South African Thoroughbred
breeding demographic to a sales complex. Nasal swabs for quantitative real-time polymerase chain reaction
(qPCR) assay to detect EHV-1 and -4 nucleic acid and blood samples for enzyme-linked immunosorbent assay
for EHV-1 and -4 antibodies were collected from all horses on arrival and departure. Additional nasal swabs for
qPCR were obtained serially from those displaying pyrexia and, or nasal discharge. Daily faecal samples were
used for determination of faecal glucocorticoid metabolite (FGM) concentrations as a measurement of physiological
stress and these values were modelled to determine the factors best explaining FGM variability.
Results: EHV-4 nucleic acid was detected in 14.4 % and EHV-1 from none of the animals in the study population.
Most (93.3 %) and very few (1.1 %) of this population showed antibodies indicating prior exposure to EHV-4 and
EHV-1 respectively. Pyrexia and nasal discharge were poor predictors for detecting EHV-4 nucleic acid. The horses’
FGM concentrations increased following arrival before decreasing for most of the remaining study period including the
auction process. Model averaging showed that variation in FGM concentrations was best explained by days post-arrival
and transport duration.
Conclusions: In this study population, sales consignment was associated with limited detection of EHV-4 nucleic
acid in nasal secretions, with most showing prior exposure to EHV-4 and very few to EHV-1. The physiological stress
response shown by most reflected the combination of stressors associated with transport and arrival and these are
key areas for future investigation into management practices to enhance health and welfare of young Thoroughbreds
during sales consignment.
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Equine respiratory infection is an important cause of
disease and economic loss worldwide resulting in signifi-
cant wastage, particularly in the Thoroughbred racing
industry, due to lost training days, prolonged absence
from racing and possible negative effects on long-term
athletic performance [1, 2]. Equine herpesvirus types-1
and -4 (EHV-1 and -4) are important agents associated
with infectious upper respiratory tract disease (IURD)
[3–5]. Few surveillance studies to detect these viruses
are reported in healthy horse populations [6, 7].
Risks associated with IURD are multifactorial, including
host, environmental, management and pathogen-specific
factors [8, 9]. Age as a risk factor in juvenile horses has
been well recognised with higher detection rates of
EHV-1 and -4 reported during the colder winter
months [3, 4, 8–12]. Physiological stress is arguably one of
the more important risk factors, with associations reported
between EHV-1 and -4 recrudescence and shedding and
various exogenous stressors, as well as experimental cor-
ticosteroid administration [13–15]. Stress may further in-
crease the susceptibility of naive animals to new infections
[13]. Transport and the subsequent confinement, handling
and management at sales events may contribute to
physiological stress [10, 12, 13, 16]. Large, intermingled
assemblages of horses from diverse sources provide an op-
portune environment for viral shedding and transmission,
exacerbated by potentially stressful disruption of estab-
lished social groups [9, 10, 17]. Detection of EHV-1 from
nasal secretions following long distance transport of
horses and both EHV-1 and -4 upon horses’ arrival and
shortly thereafter at North American sales and show
events have been reported [12, 16].
Measurement of faecal glucocorticoid metabolite
(FGM) concentrations to monitor adrenocortical func-
tion in horses provides a practical, non-invasive and
feedback-free alternative to glucocorticoid (e.g., cortisol)
determination in blood, saliva, urine or milk [17, 18].
FGM concentrations unlike rapidly-fluctuating blood
cortisol levels reflect cumulative secretion and elimin-
ation of hormones over an extended interval. A delayed,
time-averaged response to a stressor is provided depend-
ant on species-specific gut-passage times, with an inter-
val of approximately 24 h in horses [18, 19]. Fluctuations
in FGM concentrations have been reported for deter-
mining stress responses in horses, including animals
consigned to sales and following short, medium and
long-distance road transport [17, 20, 21].
The effects of sales consignment on detection of viral
nucleic acids and physiological stress responses among
young Thoroughbreds have not been reported previ-
ously. This study aimed to detect EHV-1 and -4 nucleic
acids in nasal secretions of young Thoroughbreds at a
South African auction sale. It also aimed to determinewhich factors among: EHV-4 nucleic acid detection,
clinical signs of respiratory disease, transport and prep-
aration for auction explained variability in FGM con-
centrations, as an indicator for physiological stress.
Methods
The study was approved by the Animal Ethics Committee
of the University of Pretoria (Study V040-13).
Animals
The study population included 90 (51 colts, 39 fillies) of
the 358 two-year old Thoroughbred horses catalogued
for an annual auction sale in South Africa. The horses
enrolled were pre-selected from the sales catalogue
based on owners’ consent to participate and the avail-
ability of accurate records from the particular farms.
Selected horses originated from eight farms situated in
three provinces: 30 from three (Farms 1, 2 and 3) in the
Western Cape Province, 18 from two (Farms 4 and 5)
in the Eastern Cape Province and 42 from three (Farms
6, 7 and 8) in KwaZulu-Natal Province. This selection
was representative of the South African Thoroughbred
breeding demographic.
Housing at the complex consisted of 44 barn-style
buildings, subdivided into 771 individual stables and
separated by walkways. Each farm’s consigned horses
were allocated a unique stable number and housed in
adjacent stables, although often within the same barn as
horses from other farms. The buildings’ design allowed
for free movement of air between stables and windows
with metal grids enabled nose-to-nose contact between
horses in adjacent stables. Horses were periodically
removed from their stables into adjacent walkways for
showing or grooming and mixed randomly at communal
facilities during routine daily activities including in-hand
exercise and washing. Daily care activities of the horses,
including feeding, were performed by the staff of the
respective farms according to each farm’s protocol. All
enrolled horses were vaccinated against equine influenza
virus, African horse sickness and tetanus, but none
against EHV-1 or -4. Informed, written consent for
participation was obtained from the owners of each
participating farm.
Study design
A prospective cohort study was performed during the
late southern hemisphere winter at the Thoroughbred
Breeders Association National Two Year Old Sales in
Germiston, Gauteng Province of South Africa. Horses
travelled by road transport and arrived at the sales
complex on various dates. Their residence period there-
fore varied between four and nine days. The auction
occurred over two days (15 and 16 August 2013), with
each horse’s date of auction regarded as the end-point of
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departure. For half of the horses, FGM data were also
collected on the day post auction. For each horse, the
period from its day of arrival until the third day post-
arrival was defined as the ‘adaptation phase’. For each
horse, the period including the day prior to and the day
of its auction was defined as the ‘auction phase’. These
phases were defined a priori to allow comparison of data
from horses with varying periods of residence.
Sample collection and analyses
Sample collection
At arrival One nasal swab, a blood sample and a faecal
sample were collected from each horse within 24 h of
arrival. Nasal secretion samples were collected using a
15 cm metal shaft rayon-tipped swab¹ advanced into
either of the horse’s nostrils and gently rotated against
the mucous membranes for collection of nasal secretion
and epithelial cells. Following collection the swab was
replaced in its sterile, dry plastic tube and refrigerated
at 4-6 °C until delivery to the Veterinary Genetics
Laboratory, University of Pretoria. Laboratory process-
ing of nasal swabs was performed within 48 h of
collection. One 8.5 ml BD Vacutainer® SSTTM II
Advance Plus serum tube² was filled with blood from
each horse by means of jugular venipuncture. Blood
samples were refrigerated at 4-6 °C following collection,
until delivery to the Immunocontraception Laboratory,
University of Pretoria. A faecal sample was collected from
each horse’s stable between 06 h00-09 h00 in a 25 ml
plastic specimen container, frozen at -20 °C within 2 h of
collection and kept frozen until delivery to the Endocrine
Research Laboratory, University of Pretoria.
Daily monitoring From arrival until departure horses were
monitored twice daily, between 06 h00-09 h00 and 15 h00-
18 h00 with rapid digital thermometers (Thermoval®³) for
pyrexia, defined as a rectal temperature ≥ 38.5 °C. Horses
were additionally monitored once daily, between 06 h00-
09 h00, for the presence of an obvious nasal discharge.
Daily sampling of horses with pyrexia and, or nasal
discharge Subsequent to recording a pyrexia and, or
nasal discharge in any horse, serial nasal swabs were
collected daily as described until the day of departure.
Daily sampling of study population
Faecal samples were collected daily as described.
Prior to departure
One nasal swab, a blood sample and a faecal sample
were collected as described from each horse following
their auction, within 24 h prior to their departure.Laboratory analyses
Quantitative real-time polymerase chain reaction
(qPCR) for EHV-1 and -4 deoxyribonucleic acid
(DNA) Nasal swabs were agitated for 5 s in 0.5 ml of
0.1 M phosphate buffered saline (pH 7.4) in a 1.5 ml
Eppendorf tube. Nucleic acid was extracted from
100 μl of the preparation using MagMaxTM Pathogen
DNA/RNA kit⁴ and a Kingfisher 96 Magnetic Particle
Processor⁵ according to manufacturer’s protocols.
Subsequently, a duplex qPCR for EHV-1 and -4 was
performed using previously described primers and
probes [22]. Briefly, 17 μl of a master mix consisting
of 1 μl of each primer/probe mix, 5 μl of nuclease-free
water and 10 μl of Kapa Probe Fast ABI Prism® 2X
PCR master mix⁶ was added to each well of a PCR
plate and 3 μl of the extracted template was added.
EHV-1 and EHV-4 reference viral cultures were ob-
tained from the Equine Virology Research Laboratory,
University of Pretoria. Aliquots of nucleic acid extracted
from these reference virus cultures were included on each
plate as positive controls with nuclease free water being
included as a negative control. The qPCR was performed
according to the manufacturer’s protocol with the assign-
ment of a cut-off value of < 40 cycles (Ct) for positive
detection of viral DNA.Enzyme-linked immunosorbent assay (ELISA) for
EHV-1 and -4 antibodies Each serum sample was
tested against the glutathione-S-transferase (GST)
fusion proteins of EHV-1 glycoprotein G, EHV-4 glyco-
protein G and against GST only, as previously
described by Crabb and Studdert [23] and validated by
Gilkerson et al. [24]. To increase the sensitivity of the
assay and assess inter-sample variation, all samples
were tested against each antigen in duplicate and the
mean absorbance of the two tests was used as the test
result. The following cut-off levels were used for inter-
pretation of the absorbance values: > 0.2 for antibody-
positive; 0.1-0.2 for indeterminate; and < 0.1 for
antibody-negative. Positive control samples for EHV-1
and EHV-4 antibodies were included on each plate. All
antigens and positive control samples used in these
assays were obtained from the Centre for Equine
Virology, University of Melbourne.Faecal extraction and hormone analysis Frozen faecal
samples were lyophilized, pulverized and sifted using
a metal mesh strainer to remove fibrous material
[25]. Between 0.10-0.11 g of the faecal powder was
then extracted by vortexing for 15 min with 80 %
ethanol in water (3 ml). Following centrifugation for
10 min at 1500 g, supernatants were transferred into
micro-centrifuge tubes and stored at −20 °C until
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FGM concentrations using an enzyme immunoassay
that detects 11,17-dioxoandrostanes, previously shown
to provide reliable information on adrenocortical function
in various mammals, including horses [26–28]. Serial
dilutions of extracts gave displacement curves parallel to
the standard curve of the assay. Sensitivity of the
assay at 90 % binding was 1.8 ng/g faeces. Intra-
and inter-assay coefficients of variation, determined
by repeated measurement of high- and low-value
quality controls, ranged between 1.9 % and 16.5 %.
The assay was performed as previously described
using antibodies for which cross-reactivity’s have
been reported [29, 30].Statistical analyses
To determine which factors best explained variability in
physiological stress in our study animals, we modelled
the natural-log-transformed FGM concentrations from
655 faecal samples in linear mixed models, fitted with
the ‘identity’ link function, using lmer in Package ‘lme4’
in R [31]. The global model included six standardized
fixed effects: days post arrival; auction phase (including
the preparation day one day prior to auction and the
auction day); transport duration; pyrexia; nasal dis-
charge; EHV-4 DNA detection. Transport duration
ranged from 6 to 22 h (median: 15.25 h). Repeated mea-
sures were modelled as random effects: horse identity
(1|horse); farm identity (1|farm). Candidate models were
evaluated with Akaike’s Information Criterion (AICc)
[32]. Model averaging was performed using Akaike
weights (wi) of all candidate models [33]. Goodness of fit
of parameter estimates was assessed using 85 % confi-
dence intervals and Ω0
2 for the global model [34, 35].
Collinearity among covariates was assessed with variance
inflation factors (with a priori values of > 5 deemed







Sample dates (August 2013)
8 9 10
1 Western Cape 13 0/13 1/8
2 Western Cape 9 0/9 2/5
3 Western Cape 8 0/8 0/5 0/5
4 Eastern Cape 13 1/13
5 Eastern Cape 5 0/5
6 KwaZulu-Natal 10
7 KwaZulu-Natal 26 0/26 0/16
8 KwaZulu-Natal 6
Number (%) 90 0/8 (0) 0/53 (0) 4/52 (7.7
a = auction datesResults
EHV nucleic acid detection
No EHV-1 DNA was detected, however EHV-4 DNA
was detected in nasal secretions of 13/90 (14.4 %)
horses originating from 7/8 participating farms (Tables 1
and 2). A total of 21 swabs positive for EHV-4 DNA
were obtained from these 13 horses. Repeated incidents
of EHV-4 DNA detection occurred in 4/13 (30.8 %)
horses. Both the longest period of continuous detection
and the longest interval between consecutive detection
events in an individual horse, were four days. Nasal
swabs from 1/90 (1.1 %) and 7/90 (7.8 %) horses were
positive for EHV-4 DNA on day of arrival and depart-
ure, respectively. Details of the temporal pattern of
EHV-4 nucleic acid detection during the observation
period are shown in Table 1. The EHV-4 qPCR-results
for 13 horses from which EHV-4 DNA was obtained in
their nasal secretions, are shown in Table 2.EHV-4 nucleic acid detection and clinical signs
All 13 horses from which nasal swabs positive for
EHV-4 DNA were obtained showed either nasal dis-
charge alone, or both pyrexia and nasal discharge
during the observation period (Table 3). However, 65/77
(84.4 %) horses in which EHV-4 DNA was not detected
also showed one or both of these clinical signs (Table 3).
Duration of pyrexia was less than 24 h in 7/8 horses with
concurrent detection of EHV-4 DNA.EHV-1 and -4 serology
Upon arrival at the sales complex, 1.1 % and 93.3 % of
the study population showed serological evidence of
prior exposure to EHV-1 and EHV-4, respectively. No
instances of seroconversion were recorded between
arrival and departure. Only one horse (Horse E) of the
13 from which qPCR-evidence of EHV-4 DNA was
detected in its nasal secretions, was EHV-4-seronegativeobtained from 90 Thoroughbreds at an auction sale
11 12 13 14 15a 16a
0/9 0/9 0/9 0/9 0/12 0/5
0/5 0/5 0/6 1/7 1/8 1/5
0/5 1/6 1/7 1/7 1/8 1/5
0/4 0/4 0/7 0/7 3/12 0/4
0/1 0/3 1/3 2/4 1/5 0/1
0/10 0/0 1/3 0/5 0/8 0/3
0/16 0/17 0/18 0/19 1/25 0/9
0/6 0/1 0/6 0/2
) 0/50 (0) 1/44 (2.3) 3/59 (5.1) 4/59 (6.8) 7/84 (8.3) 2/34 (5.9)
Table 2 qPCR-results from 13 Thoroughbreds with detection of EHV-4 nucleic acids in their nasal secretions
= horse not present at sales complex; (−) = EHV-4 qPCR-negative; (a) = EHV-4 qPCR-positive with Ct (cycle threshold) value; n/s = no swab collected;
∞ = sampling not possible
Table 4 Models with Akaike weights (wi) > 0 and ΔAICc < 10,
modelling faecal glucocorticoid metabolite concentrations in
horses
Model: log(FGM) ~ logL K AICc Δ w
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days later.
FGM concentrations
None of the covariates in our models exhibited un-
acceptable collinearity: all variance inflation factors
were < 2.2. Several models contained a similar amount
of information or explained a similar amount of vari-
ability in FGM’s (i.e., ‘best models’ with AICc < 10,
Table 4), suggesting that model averaging was an
appropriate approach. Based on model averaging, the
covariates that best explained variation in FGM con-
centrations were days post arrival, transport duration,
and pyrexia, which all had large standardized effect
sizes and differed from zero (Fig. 1). Days post arrival
was selected in all of the best candidate models, but
transport duration was almost as important (Fig. 1)Table 3 Detection of EHV-4 nucleic acid and clinical signs





Number (%) of study
population
- - - 12 (13.3)
- + - 13 (14.4)
- - + 25 (27.8)
- + + 27 (30)
+ - - 0 (0)
+ + - 0 (0)
+ - + 5 (5.6)
+ + + 8 (8.9)
(+) = detected; (−) = not detectedand was only left out of two of the best models
(Table 4). Although the parameter estimate for pyrexia
differed from zero, this covariate had a relatively
smaller standardized effect size than those of the
transport-associated parameters (Fig. 1) and it had
relatively lower importance (it was not selected in the
second best candidate model, Table 4). The auction
phase, EHV-4 DNA detection, and nasal discharge pa-
rameters all had either high variability in parameter
estimates or a small effect size (Fig. 1). The global
model explained 31 % of variation in FGM concentra-
tions, with Ω0
2 = 0.31.i
days + duration + discharge + EHV-4
+ pyrexia + (1|farm) + (1|horse)
−364.6 9 747.8 0.0 0.48
days + duration + discharge + EHV-4
+ (1|farm) + (1|horse)
−366.5 8 749.5 1.7 0.21
days + duration + discharge + EHV-4
+ pyrexia + auction + (1|farm) + (1|horse)
−364.4 10 749.5 1.7 0.21
days + duration + discharge + EHV-4
+ auction + (1|farm) + (1|horse)
−366.4 9 751.2 3.5 0.08
days + discharge + EHV-4 + pyrexia
+ (1|farm) + (1|horse)
−369.6 8 755.5 7.7 0.01
days + discharge + EHV-4 + pyrexia
+ auction + (1|farm) + (1|horse)
−369.2 9 756.9 9.1 0.01
Individual horses (1|horse) and farms (1|farm) were random effects in all models.
Fixed effects were days post arrival (days), auction phase (auction), duration of
transport (duration), pyrexia, nasal discharge (discharge), and EHV-4 DNA detection
FGM, faecal glucocorticoid metabolites; EHV-4, equine herpesvirus-4
Fig. 1 Model-averaged standardized parameter estimates with 85 %
confidence intervals for covariates explaining faecal glucocorticoid
metabolite (FGM) concentrations in horses. Importance indicates the
sum of Akaike weights for all models containing the parameter
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the results of the model averaging and suggested that
median FGM concentrations for the eight farms in-
creased (with increased variability) after arrival, before
decreasing in concentration and variability (to approxi-
mately 40 ng/g dry weight) for most of the remainder of
the study period (Fig. 2). During the adaptation phase,
FGM concentrations were 64 % higher and 93 % higher
on the day of arrival and one day after arrival, respect-
ively, when compared to three days after arrival (Fig. 2A,
and represented by the largest effect size in Fig. 1). No
discernible increase in FGM concentrations was associ-
ated with the auction phase (Fig. 2B, and represented by
small effect size with a confidence interval overlapping
zero in Fig. 1).
Discussion
Detection rates of EHV-4 and EHV-1 DNA in nasal
secretions from the study population horses were higher
and lower, respectively, than those reported in popula-
tions showing clinical signs of respiratory disease [4, 5].
It was previously suggested that EHV-1 rarely circulatesFig. 2 Faecal glucocorticoid metabolite (FGM) concentrations of consignin
represent median FGM concentrations for horses from different farms on eac
Day “+1” in panel B indicates the day post-auction for which faecal samples w
approximately 24 h, FGM values reflect physiological stress responses to stimuoutside breeding populations inclusive of young foals
[12]. In the present study, EHV-4 DNA detection
included single and repeated, continuous or interrupted
events and the relatively low rate of detection upon sales
arrival was similar to a previous report [12]. Most EHV-4
detection events coincided with the dates of the two
auction days, peaking on the first of these days. Both viral
recrudescence and horizontal spread of primary infection
may have contributed to the increased detection of EHV-4
DNA observed between arrival and departure [13, 14].
The study population showed a greater seroprevalence of
EHV-4 compared to EHV-1, reflecting that prior exposure
on the farms of origin was almost universal or only in a
few individuals, to EHV-4 and EHV-1 respectively. This
seroprevalence was similar to previous reports from
different populations, including two-year old racehorses in
Australia [13, 36, 37]. EHV-4 DNA was detected in the
nasal secretions of 12 horses despite the presence of
EHV-4 antibodies, most likely as a result of viral recru-
descence. In the case of Horse E, EHV-4 DNA detec-
tion likely resulted from recent primary EHV-4
infection with nasal shedding of virus and serum sam-
ple collection prior to establishment of a detectable
antibody response. The implications of EHV-1 and -4
DNA detection at sales departure and the associated
risks of viral shedding and transmission at subsequent
destinations, including training facilities, warrant fur-
ther investigation.
In this study we observed a similar prevalence of
pyrexia and a higher prevalence of nasal discharge than
previously reported among EHV-4-positive horses [4].
Clinical signs was a poor indicator for viral nucleic acid
detection, with several horses that showed clinical signs
being negative for EHV-4 DNA, contrasting with a
reported association between clinical signs of respiratory
disease and EHV-4 detection in foals [38]. A pyrexia
duration < 24 h in the majority of EHV-4 qPCR-g farms (n = 8) during the adaptation (A) and auction (B) phase. Circles
h day. Lines connect daily medians of the 8 farm median FGM values.
ere obtained from half of the study’s horses. With a gut passage time of
li experienced on the previous day
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rectal temperature monitoring for suspected clinical
cases [9, 39]. A study limitation was the reliance of
nasal swabbing on observation of clinical signs, poten-
tially resulting in lower detection rates of sub-clinical
EHV-1 and -4 infections. The combination of pyrexia and
nasal discharge was reported in association with molecular
evidence of lesser characterised respiratory viruses EHV-2,
EHV-5, equine adenovirus-1 and equine rhinitis B [40].
The current study’s discrepancy in the prevalence of
clinical signs and detection of EHV-1 and -4 warrants
further investigation of the association of IURD with alter-
native infectious agents during sales consignment.
Sales consignment was associated with an elevation
in FGM concentrations shortly after arrival. This
presumably reflected a cumulative series of stressful
events associated with transport and sales arrival, and
gradually decreased as horses became accustomed to
environmental and routine changes. The covariates that
best explained the variation in FGM concentration in
order of importance were the number of days post-
arrival, transport duration and pyrexia. The EHV-4
DNA detection threshold on qPCR was lower than that
reported by Diallo et al. [22] which may explain the
observation that EHV-4 DNA was not an important
covariant in our model. Notably, the auction process
itself did not appear to initiate any prolonged physio-
logical stress.
Practicalities precluded monitoring of case-matched
horses on the farms of origin for EHV-1 and -4 DNA
detection and FGM alterations.Conclusions
EHV-4 DNA was detected in nasal secretions of some
young Thoroughbreds consigned to a South African
auction sale. Most of these horses had been exposed to
EHV-4 and very few to EHV-1 prior to their arrival at
the sale. The combination of stressors associated with
their transport and arrival was associated with most
horses showing a physiological stress response. These,
other stressors and commingling inherent to the
current worldwide consignment process increase the
risk association with IURD in young horses. The trans-
port and arrival phases are key areas for future investi-
gation into management practices to reduce the impact
of physiological stress on the health and welfare of
young Thoroughbreds during sales consignment.
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